Moleculin Appoints Dr. Sandra Silberman as Chief Medical Officer -- New Products
HOUSTON, TX--(Marketwired - November 08, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which …